ERBB2 and breast carcinoma: Since biochanin A is a methyl derivative of genistein, we hypothesized that biochanin A inhibits HER-2 receptor activation and downstream signaling pathways associated with growth, viability, and invasion of HER-2+ breast cancer cells.